Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sumitomo Pharma Co., Ltd.
Age
18–74
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who are considered by the investigator eligible for the present study with no significant safety concerns
Patients who are fully informed of and understand the objectives, procedures, and possible benefits and risks of the study and who provide written voluntarily consent to participate in the study
You may not be if
Patients who are planning pregnancy for the expected duration of the study
Patients who are otherwise considered ineligible for the study by the investigator
Clareo Health | Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
